ACM
ELV icon

AlphaCrest Capital Management’s Elevance Health ELV Stock Holding History

AlphaCrest Capital Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-5,984
Closed -$2.72M – 362
2022
Q3 		$2.72M Buy
5,984
+1,357
+29% +$649K 0.17% 125
2022
Q2 		$2.23M Buy
4,627
+3,917
+552% +$1.94M 0.11% 271
2022
Q1 		$349K Sell
710
-3,006
-81% -$1.37M 0.02% 1051
2021
Q4 		$1.72M Buy
3,716
+1,163
+46% +$489K 0.06% 509
2021
Q3 		$952K Sell
2,553
-8,913
-78% -$3.39M 0.05% 637
2021
Q2 		$4.38M Buy
11,466
+7,567
+194% +$2.89M 0.19% 132
2021
Q1 		$1.4M Buy
3,899
+700
+22% +$225K 0.08% 378
2020
Q4 		$1.03M Sell
3,199
-8,629
-73% -$2.65M 0.09% 309
2020
Q3 		$3.18M Buy
11,828
+2,230
+23% +$600K 0.35% 32
2020
Q2 		$2.52M Sell
9,598
-7,601
-44% -$2.03M 0.42% 25
2020
Q1 		$3.9M Buy
17,199
+4,031
+31% +$1.1M 0.47% 6
2019
Q4 		$3.98M Sell
13,168
-9,750
-43% -$2.68M 0.33% 36
2019
Q3 		$5.5M Buy
22,918
+13,434
+142% +$3.68M 0.33% 24
2019
Q2 		$2.68M Sell
9,484
-7,037
-43% -$1.92M 0.23% 90
2019
Q1 		$4.74M Buy
16,521
+13,921
+535% +$4.03M 0.72% 9
2018
Q4 		$683K Buy
+2,600
New +$715K 0.2% 143

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

AlphaCrest Capital Management's ELV Position: Q4 2022 in Review

AlphaCrest Capital Management sold out of Elevance Health (ELV) in Q4 2022, closing a stake of 5,984 shares — an estimated $2.72M sold.

AlphaCrest Capital Management first reported a position in ELV in Q4 2018 and held it in 16 quarters. The position peaked at $5.5M in Q3 2019. 1,548 funds tracked by Wall St. Rank hold ELV as of Q4 2022.

  • AlphaCrest Capital Management reported no remaining Elevance Health position as of Q4 2022 after selling out during the quarter.
  • AlphaCrest Capital Management sold 5,984 Elevance Health shares in Q4 2022, an estimated $2.72M.
  • AlphaCrest Capital Management first reported a position in Elevance Health in Q4 2018 and held it in 16 quarters.
  • AlphaCrest Capital Management's Elevance Health position peaked at $5.5M in Q3 2019.
  • 1,548 funds tracked by Wall St. Rank held Elevance Health as of Q4 2022.

Based on AlphaCrest Capital Management's 13F filing for Q4 2022.